Through interviews with executives at 15 leading biopharmaceutical and medical device companies, JLL has uncovered three trends pointing toward the future laboratory space. Building Design + Construction takes a look.
Shorter research and development (R&D) timelines, ongoing cost pressures and sudden shifts in research priorities are driving new trends in lab design and location. Flexible space and access to talent are the keys to agile R&D, according to a new report from JLL, Journey to the next gen lab.
The average return on R&D investments among large biopharmaceutical firms has declined dramatically from 10.1% in 2010 to a paltry 3.2% in 2017. In the race for breakthrough innovations, companies are seeking collaboration and more flexible facilities.
“As a result of organizational cost pressures and a stronger focus on shortening the product lifecycle, R&D real estate is becoming multiuse,” says Roger Humphrey, Executive Managing Director and leader of JLL’s Life Sciences group. “The result is a drive toward highly flexible and attractive workplaces that appeal to not only scientific, but technical talent.”
Click here to find out why it’s all about flexibility and talent for the future of life sciences.